Pacific biosciences of california, INC. Indefinite delivery indefinite quantity (IDIQ) contract for sequel-sequel II product family specialized scientific equipment, reagents and services.

Ended Awarded Last action

Contract number
12805B21F0117
Awardee
Awarding agency
Obligated
$706,610

Award facts

Contract value 88% obligated
  • $706,610.00 Current, with exercised options
  • $806,610.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Kerrville, TX 78028, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00002 $50,000
Exercise an Option P00001 $50,000
Original award $606,610

About this award

Pacific Biosciences of California, Inc. was awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract valued at $806,610 by a civilian federal agency (Plains Area) on August 1, 2021, extending through July 31, 2026. This firm fixed-price delivery order contract provides specialized scientific equipment, reagents, and services from Pacific Biosciences' Sequel and Sequel II product family of long-read DNA and RNA sequencing platforms. The contract does not include a set-aside designation and is performed at the company's facility in Kerrville, Texas. As a leading biotechnology manufacturer headquartered in Menlo Park, California, Pacific Biosciences supplies advanced next-generation sequencing solutions, including complete instrument systems, consumables such as SMRT cells and reagent kits, and comprehensive maintenance and technical support services to federal research agencies.

This IDIQ award represents one of Pacific Biosciences' primary vehicles for federal procurement, complementing the company's larger $13.5 million IDIQ with the U.S. Department of Agriculture Agricultural Research Service and its $1 million FDA contract. Through these contracting relationships, Pacific Biosciences delivers critical genomic sequencing capabilities supporting federal research initiatives across multiple civilian agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, and Department of the Navy. The company's extensive federal contracting portfolio, totaling tens of millions of dollars across prime and subcontract awards, demonstrates broad recognition of its technological capabilities in advancing agricultural genetics research, infectious disease analysis, biotechnology development, and regulatory science across the U.S. government.

Quick answers

Who was awarded contract 12805B21F0117?

12805B21F0117 was awarded to Pacific Biosciences Of California, Inc. by Plains Area (Field Research Implementation and Information Delivery) on August 1, 2021.

How much is contract 12805B21F0117 worth?

The government has obligated $706,610 on 12805B21F0117. Its potential value, with all options, is $806,610.

Is contract 12805B21F0117 an order under another contract?

Yes. 12805B21F0117 is a delivery order under 12405B21D0002, an indefinite delivery contract.

Was contract 12805B21F0117 competed?

The extent of competition for 12805B21F0117 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award